# Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients

> **NCT05755581** · PHASE1 · UNKNOWN · sponsor: **Sohag University** · enrollment: 100 (estimated)

## Conditions studied

- Female Breast Cancer

## Interventions

- **DRUG:** Hormonal Antineoplastics
- **DRUG:** Chemotherapy drug

## Key facts

- **NCT ID:** NCT05755581
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-01
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05755581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05755581, "Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05755581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*